AVN Goes To Russell Index !!!!!!!!! -- Stock Picks

[ Show ]

Support VoyForums

[ Shrink ]

VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1, 2 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 06:24:25 07/02/01 Mon
Author: AVN Goes To Russell Index !!!!!!!!!
Subject: AVN Goes To Russell Index !!!!!!!!!

AVN Goes To Russell Index !!!!!!!!!

Advantages: A well diversified index for smaller companies which have
great growth potential.

http://www.russell.com/US/Indexes/US/membership/recon_additions.asp

AVN / expect ''meteoric bull market ...''

Amex stocks poised for explosive summer rally

"..Avanir Pharmaceuticals (AVN) is a prime example of what happens when the lines of supply that have
suppressed a stock�s price are finally overcome (viz., its trendlines get broken). After a one-year
downward trend, AVN moved higher last week in explosive fashion, which we believe is a harbinger of
what many other stocks across the board will experience later this spring. You can expect a pullback
(or at least a consolidative rest) in AVN sometime in the next few days. However, AVN must be
considered a technical buy candidate and not just a one-hit wonder. If AVN overcomes $9 ultimate
resistance, expect a meteoric bull market this summer in this stock. "

--Clif Droke
iStockForecast.com

also remember...

AVN institutional ownership has practically tripled in a short period of time. The big boys seem content in gradually accumulating the shares from retail shareholders who continue to hold on tight. One can only imagine how successful AVN will be if institutional ownership continues to grow as large as it's nearest competitor MEDX with 60%. With still only 3.2%, it seems AVN has rocketship potential considering that they feel their Xenerex technology is better than MEDX and they have the first OTC FDA approved herpes cream being marketed successfully as "Abreva" through Glaxo SmithKline.

AVN Could Be the New Mab Leader

Interesting news in the biotech world has arrived. Eos has signed the first partnership with AVN's Xenerex which will
compete with MEDX, ABGX and PDLI in making fully human monoclonal antibodies. What's even more interesting is that
Eos' chairman of the board is Nicholas Pritzker and a major investor in Eos is the Pritker Family's BCC bank. The Pritzkers are the multibillionairs of Hyatt Hotel fame who were instumental is the growth of MEDX. The Pritzkers
through BCC were one of MEDX's largest investors. Immediately after the deal with AVN, Eos announced that they were
retuning $5M to MEDX which was in the terms of an already existing deal. One has to assume that the terms of the contract
being changed were in connection with the AVN/Xenerex deal. Why would the Pritzkers lean towards AVN/Xenerex now?
Perhaps this has something to do with it...

"Using immuno-deficient mice, rather than transgenic mice, Xenerex can produce completely human
antibodies faster and cheaper than its
competition, big market players like Abgenix Inc., Medarex Inc. and Cambridge Antibody
Technology plc, Hansen said. "

Bioworld Online,
Aug 21, 2000

[ Next Thread | Previous Thread | Next Message | Previous Message ]